ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Semaglutide impurity 104
C25H26N4O5
462.5 g/mol
Research Reagent

Semaglutide impurity 104

CAS2171211-18-8
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

This compound is a peptide-based research reagent used as a reference standard for impurity analysis in the quality control of semaglutide. It is structurally characterized as an Fmoc-protected dipeptide containing D-histidine and alpha-methylalanine.

reference standard for impurity analysis in semaglutide manufacturingresearch reagent for peptide impurity profiling

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Semaglutide impurity 104?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

N-Hydroxy-5-norbornene-2,3-dicarboximide

CAS21715-90-2

research compound

ReferenceSame Category

2-Amino-5-fluoropyridine

CAS21717-96-4

research compound

ReferenceSame Category

Bis(chloraniumyl)palladium 2-{[bis(2,4-di-tert-butylphenoxy)phosphanyl]oxy}-3,5-di-tert-butylbenzen-1-ide--palladium (1/2/1)

CAS217189-40-7

research compound

ReferenceSame Category

2-{2-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]acetamido}acetic acid

CAS2172233-55-3

research compound

Referencestereoisomer of

Fmoc-His-Aib-OH

CAS1446013-07-5

pharmaceutical intermediate

Referencesame scaffold

1-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-histidine

CAS81379-52-4

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

2-[[(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1H-imidazol-5-yl)propanoyl]amino]-2-methylpropanoic acid

InChIKey

DRXNKOXLDLFGEG-OAQYLSRUSA-N

SMILES

CC(C)(C(=O)O)NC(=O)[C@@H](CC1=CN=CN1)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24

Synonyms (4)
  • Fmoc-D-His-Aib-OH
  • Semaglutide impurity 104

Sourcing Semaglutide impurity 104?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→